Literature DB >> 27708905

Chondrodermatitis nodularis chronica helicis in a patient with systemic sclerosis associated with primary biliary cirrhosis (Reynolds syndrome): A case report.

Walter Alberto Sifuentes Giraldo1, Carmen González-García2, Elena de Las Heras Alonso3, Carlos de la Puente Bujidos1.   

Abstract

Chondrodermatitis nodularis chronica helicis is a rare non-neoplastic inflammatory and degenerative process of the external ear, characterized by necrobiotic changes in the dermis that extend down to the perichondrium. This condition has been occasionally reported in patients with limited cutaneous systemic sclerosis but not in those with concomitant primary biliary cirrhosis; this association is known as Reynolds syndrome. We report a 70-year-old woman diagnosed with primary biliary cirrhosis at age 47 and with limited cutaneous systemic sclerosis at age 54 who developed a painful ulcerated nodule on the helical rim of the left ear shortly after the last diagnosis. The lesion was excised because of the suspicion of malignancy, but the histopathology was consistent with chondrodermatitis nodularis chronica helicis. Although this condition is infrequent, it is necessary to know, because it may occur in patients with systemic sclerosis and be mistaken for neoplasms, such as basal cell and squamous cell carcinoma, and these patients have an increased risk for the development of skin malignancies.

Entities:  

Keywords:  Chondrodermatitis nodularis chronica helicis; Reynolds syndrome; primary biliary cirrhosis; skin malignancies; systemic sclerosis

Year:  2014        PMID: 27708905      PMCID: PMC5042248          DOI: 10.5152/eurjrheumatol.2014.140048

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  9 in total

1.  Chondrodermatitis nodularis helicis in childhood dermatomyositis.

Authors:  T Sasaki; H Nishizawa; Y Sugita
Journal:  Br J Dermatol       Date:  1999-08       Impact factor: 9.302

2.  A case of chondrodermatitis nodularis chronica helicis with an autoantibody to denatured type II collagen.

Authors:  E Yoshinaga; U Enomoto; N Fujimoto; Y Ohnishi; S Tajima; A Ishibashi
Journal:  Acta Derm Venereol       Date:  2001-05       Impact factor: 4.437

Review 3.  Clinical appearance, differential diagnoses and therapeutical options of chondrodermatitis nodularis chronica helicis Winkler.

Authors:  Gunnar Wagner; Jan Liefeith; Michael Max Sachse
Journal:  J Dtsch Dermatol Ges       Date:  2011-01-31       Impact factor: 5.584

4.  Chondrodermatitis nodularis chronica helicis; report of ninety-four cases and survey of literature, with emphasis upon pathogenesis and treatment.

Authors:  V D NEWCOMER; C G STEFFEN; T H STERNBERG; L LICHTENSTEIN
Journal:  AMA Arch Derm Syphilol       Date:  1953-09

5.  Chondrodermatitis nodularis helicis.

Authors:  Lester D R Thompson
Journal:  Ear Nose Throat J       Date:  2007-12       Impact factor: 1.697

6.  Skin manifestations of liver diseases.

Authors:  A Koulaouzidis; S Bhat; J Moschos
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

7.  Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome.

Authors:  T B Reynolds; E K Denison; H D Frankl; F L Lieberman; R L Peters
Journal:  Am J Med       Date:  1971-03       Impact factor: 4.965

8.  Chondrodermatitis nodularis helicis occurring with systemic sclerosis--an under-reported association?

Authors:  W W Bottomley; M D Goodfield
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

9.  Advances in the understanding of chondrodermatitis nodularis chronica helices: the perichondrial vasculitis theory.

Authors:  T Upile; N N Patel; W Jerjes; N U Singh; A Sandison; L Michaels
Journal:  Clin Otolaryngol       Date:  2009-04       Impact factor: 2.597

  9 in total
  1 in total

Review 1.  Review of the Etiopathogenesis and Management Options of Chondrodermatitis Nodularis Chronica Helicis.

Authors:  Haneen Salah; Brittany Urso; Amor Khachemoune
Journal:  Cureus       Date:  2018-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.